143 related articles for article (PubMed ID: 38652091)
1. Retraction: Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.
J Cell Mol Med; 2024 Apr; 28(8):e18313. PubMed ID: 38652091
[TBL] [Abstract][Full Text] [Related]
2. Retraction: Disruption of microRNA-214 during general anaesthesia prevents brain injury and maintains mitochondrial fusion by promoting Mfn2 interaction with Pkm2.
J Cell Mol Med; 2024 Jan; 28(2):e18095. PubMed ID: 38153171
[TBL] [Abstract][Full Text] [Related]
3. Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
J Cell Mol Med; 2024 Mar; 28(6):e18078. PubMed ID: 38073225
[TBL] [Abstract][Full Text] [Related]
4. Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.
J Cell Mol Med; 2024 Mar; 28(6):e18077. PubMed ID: 38073196
[TBL] [Abstract][Full Text] [Related]
5. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
FEBS Open Bio; 2024 Mar; 14(3):528. PubMed ID: 38149473
[TBL] [Abstract][Full Text] [Related]
6. Retraction: Tongyi Lu, Binhua Wu, Yunfei Yu, Wenhui Zhu, Simin Zhang, Yinmei Zhang, Jiaying Guo, Ning Deng. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018; 109: 2221-2234. https://doi.org/10.1111/cas.13633.
Cancer Sci; 2024 Apr; 115(4):1360. PubMed ID: 38342762
[TBL] [Abstract][Full Text] [Related]
7. Retraction.
Cancer Med; 2023 Dec; 12(24):22437. PubMed ID: 38100296
[TBL] [Abstract][Full Text] [Related]
8. Retraction.
J Cell Mol Med; 2023 Oct; 27(19):3009. PubMed ID: 37150927
[TBL] [Abstract][Full Text] [Related]
9. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579
[TBL] [Abstract][Full Text] [Related]
10. Retraction statement: Yiwen Xiao, Jingjing Pan, Qian Geng, Ge Wang (2019), LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Bio, 9: 1212-1222.
FEBS Open Bio; 2023 Sep; 13(10):1986. PubMed ID: 37724913
[TBL] [Abstract][Full Text] [Related]
11. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.
Mol Oncol; 2024 Jun; ():. PubMed ID: 38837853
[TBL] [Abstract][Full Text] [Related]
12. Retraction: Long non-coding RNA Sox2 overlapping transcript (SOX2OT) promotes multiple myeloma progression via microRNA-143-3p/c-MET axis.
J Cell Mol Med; 2024 Jan; 28(2):e18102. PubMed ID: 38153182
[TBL] [Abstract][Full Text] [Related]
13. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: A meta-analysis involving 10,947 subjects.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
J Cell Mol Med; 2018 Jul; 22(7):3703. PubMed ID: 29924497
[TBL] [Abstract][Full Text] [Related]
14. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
[TBL] [Abstract][Full Text] [Related]
15. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
[TBL] [Abstract][Full Text] [Related]
16. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21
FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074
[TBL] [Abstract][Full Text] [Related]
17. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790.
FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057
[TBL] [Abstract][Full Text] [Related]
18. Retraction statement: Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity. FEBS Open Bio, 9: 1392-1402.
FEBS Open Bio; 2023 Nov; 13(11):2158. PubMed ID: 37792303
[TBL] [Abstract][Full Text] [Related]
19. Retraction.
Cancer Sci; 2023 Jul; 114(7):3057. PubMed ID: 37211924
[TBL] [Abstract][Full Text] [Related]
20. Retraction Statement: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
Mol Oncol; 2023 Jul; 17(7):1454. PubMed ID: 37231586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
